Dr. Daniel Nadler is the founder of OpenEvidence, a medical artificial intelligence company most recently valued at $15 billion and backed by Sequoia, Kleiner Perkins, Andreessen Horowitz, Google, Nvidia, Blackstone, and Goldman Sachs. Independent studies show that more American doctors use OpenEvidence than use all other AI platforms combined. In 2025, Dr. Nadler was named to the TIME100 Health list of the most influential people in global health. In 2026, Dr. Nadler was named to the TIME100 AI list of the most influential people in AI. Prior to OpenEvidence, while still a Ph.D. student at Harvard, Dr. Nadler founded Kensho Technologies, which S&P Global acquired in 2018 in what was then the largest artificial intelligence acquisition in history.